Product Name:

ACK1-pY284


Product Number:

ab-pk512

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Activated CDC42 kinase 1

Target Alias: ACK; Activated Cdc42-associated kinase 1; Activated p21cdc42Hs kinase; Activated p21cdc42Hs kinase 1; Kinase ACK1; Non-receptor protein tyrosine kinase Ack; p21cdc42Hs; TNK2; Tyrosine kinase, non-receptor, 2; FLJ44758; FLJ45547; ENSG00000061938

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK511

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y284

Protein UniProt: Q07912

Protein SigNET: Q07912

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human ACK1 (TNK2) sequence peptide Cat. No.: PE-04AIA80

Antibody Immunogen Sequence: DDH(pY)VMQ(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Production Method: Corresponds to amino acid residues D281 to Q287; In protein kinase catalytic domain activation T-loop between subdomains VII and VIII.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Potency: Very weak immunoreactivity of a target-sized protein by Western blotting in FBS-treated A431 cells. Very strong immunoreactivity with immunogen peptide on dot blots.

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 120-130 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: Cross-reactivity with CDK1 and ERK1 in seastar oocytes, and with a 27 kDa protein in A431 and HEK-293 cells.

Scientific Background: ACK1 (TNK2) is a protein-tyrosine kinase of the TK group and Ack family. It appears to be a tumour suppressor protein (TSP). Cancer-related mutations in ACK1 in human tumours point to a loss of function of the protein kinase. The active form of the protein kinase normally acts to inhibit tumour cell proliferation. It is implicated in numerous roles, including: cell spreading and migration, cell survival, cell growth, and proliferation. TNK2 is known to phosphorylate: Akt1, AR, MCF2, WASL and WWOX. In this capacity TNK2 negatively regulates the tumour suppressor, WWOX, whilst activating the oncoproteins, Akt1 and AR. Mutations in this gene have been observed in ovarian, skin, and stomach tumours. Phosphorylation at Y284 in ACK1 increases its phosphotransferase activity. Its SH3 domain appears to play an autoinhibitory role.